HB 25

  • Maryland House Bill
  • 2019 Regular Session
  • Introduced in House Sep 11, 2018
  • Passed House Mar 16, 2019
  • Passed Senate Mar 28, 2019
  • Signed by Governor May 13, 2019

Public Health - Prescription Drug Monitoring Program - Revisions

Abstract

Bill Sponsors (26)

Votes


Actions


May 13, 2019

Office of the Governor

Approved by the Governor - Chapter 531

Mar 29, 2019

House

Passed Enrolled

House

Third Reading Passed (136-0)

House

House Concur - Senate Amendments

Mar 28, 2019

Senate

Third Reading Passed with Amendments (47-0)

Mar 27, 2019

Senate

Second Reading Passed with Amendments

Senate

Favorable with Amendments {367970/1 Report Adopted

Mar 25, 2019

Senate

Favorable with Amendments Report by Finance

Mar 18, 2019

Senate

First Reading Finance

Mar 16, 2019

House

Third Reading Passed (135-0)

Mar 14, 2019

House

Second Reading Passed with Amendments

House

Favorable with Amendments {866983/1 Report Adopted

House

Favorable with Amendments Report by Health and Government Operations

Feb 08, 2019

House

Hearing 2/20 at 1:00 p.m.

Jan 09, 2019

House

First Reading Health and Government Operations

Sep 11, 2018

House

Pre-filed

Bill Text

Bill Text Versions Format
Bill Text PDF PDF PDF PDF

Related Documents

Document Format
Senate Finance Committee Vote PDF
House Health and Government Operations Committee Vote PDF
Fiscal and Policy Note PDF
Amendments House - (Health and Government Operations) {866983/01 Adopted PDF
Amendments Senate - (Finance) {367970/01 Adopted PDF

Sources

Data on Open States is updated nightly from the official website of the Maryland General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.